Core Points - The company has entered into a maximum pledge contract with Zhejiang Wuyi Rural Commercial Bank to provide a guarantee for its wholly-owned subsidiary, Shouxiangu Pharmaceutical, with a maximum financing limit of RMB 30 million from August 15, 2025, to May 1, 2027 [1][4] - The company has approved a total credit limit of up to RMB 800 million for the year 2025, allowing for mutual guarantees between the company and its subsidiaries [1][4] - Shouxiangu Pharmaceutical is not a dishonest entity and has no significant issues affecting its debt repayment ability [1][4] Guarantee Details - The guarantee amount is RMB 30 million, covering all creditor rights arising from the contract, including principal, interest, and other related costs [2][4] - The guarantee period is from August 15, 2025, to May 1, 2027, and there is no counter-guarantee provided [4] - The necessity and reasonableness of the guarantee are justified by the stable operating condition of Shouxiangu Pharmaceutical, which has no major defaults or litigation issues [4] Cumulative Guarantee Information - As of the announcement date, the total external guarantees provided by the company amount to RMB 190 million, representing approximately 8.28% of the audited net assets attributable to shareholders as of December 31, 2024 [4]
浙江寿仙谷医药股份有限公司关于为全资子公司提供担保的进展公告